Critically IllNCT05112406
Early Diagnostic Biomarkers of Sepsis
An observational study of Critically Ill and Sepsis, run by Assiut University.
Trial summary
A Comparison between CRP, ferritin, and serum zinc as early diagnostic biomarkers of sepsis in critically ill patients Read more about this study
- Who is it for?
- Ages 18 to 95 years
- Conditions the study is for
- Critically Ill, Sepsis
- How many people
- 70 participants
- Where
- No sites listed yet
- Study dates
- Dec 2021to Mar 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 95 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients above 18 years old with systemic infection that may lead to sepsis.
Who may be able to join
- All patients with chest infection and UTI.
Who cannot join
- children
Trial locations and contacts
No sites are listed yet.
About this study
Official title: A Comparison Between CRP, Ferritin and Serum Zinc as Early Diagnostic Biomarkers of Sepsis in Critically Ill Patients
A Comparison between CRP, ferritin, and serum zinc as early diagnostic biomarkers of sepsis in critically ill patients
- Conditions
- Critically Ill, Sepsis
- Medical subject headings
- Critical Illness, Sepsis
What is being measured
The primary outcome is the main question the study is designed to answer.
Study of some biomarkers as indicators of sepsis.
Measurement of CRP as early diagnostic biomarker of sepsis
Measured: about 2 years
Study of some biomarkers as indicators of sepsis.
Measurement of ferritin as early diagnostic biomarker of sepsis
Measured: about 2 years
Study of some biomarkers as indicators of sepsis.
Measurement of serum Zinc as early diagnostic biomarker of sepsis
Measured: about 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Nov 2021
- Study startDec 2021 (estimated)
- Primary completionDec 2022 (estimated)
- Study completionMar 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Critically IllStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Michael Kamile Noshy Sadek, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05112406
- Sponsor's protocol ID
- Biomarkers of sepsis
- Status last verified
- Nov 2021
- First submitted
- 27 Oct 2021
- Last updated
- 8 Nov 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparison Between CRP, Ferritin and Serum Zinc as Early Diagnostic Biomarkers of Sepsis in Critically Ill Patients
- ClinicalTrials.gov ID
- NCT05112406
- Acronym / sponsor ID
- Biomarkers of sepsis
- Conditions
- Critically Ill, Sepsis
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- Dec 2021 (estimated)
- Primary completion
- Dec 2022 (estimated)
- Study completion
- Mar 2023 (estimated)
- First posted
- 8 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A Comparison between CRP, ferritin, and serum zinc as early diagnostic biomarkers of sepsis in critically ill patients
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 95 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients above 18 years old with systemic infection that may lead to sepsis.
Key inclusion criteria (1 listed)
- All patients with chest infection and UTI.
Key exclusion criteria (1 listed)
- children
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Study of some biomarkers as indicators of sepsis.
Time frame: about 2 years
Measurement of CRP as early diagnostic biomarker of sepsis
Study of some biomarkers as indicators of sepsis.
Time frame: about 2 years
Measurement of ferritin as early diagnostic biomarker of sepsis
Study of some biomarkers as indicators of sepsis.
Time frame: about 2 years
Measurement of serum Zinc as early diagnostic biomarker of sepsis
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Nov 2021.
Related trials for Critically Ill
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
Active, not recruiting
Weighted Blankets for Agitation in Adults in the Intensive Care Unit
Psychomotor Agitation, Critical Illness
Not yet recruitingObservational study
Core Competencies in General Intensive Care Ultrasound (GenIUS): a Delphi Study
Critical Illness, Ultrasound
RecruitingObservational study
Predicting Extubation Failure Using Machine Learning
Extubation Failure, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Critically Ill and Sepsis, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Michael Kamile, MBBD (+201554195616, michael.kamile@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Study of some biomarkers as indicators of sepsis. (time frame: about 2 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2021.